A1 Journal article – refereed

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study




List of Authors: Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, Rodriguez Martinez de Liano S, Liu E, Koller M, Gregg, Schenk D, Black R, Grundman M

Publication year: 2010

Journal: Lancet Neurology

Number in series: 4

Volume number: 9

Issue number: 4

Number of pages: 10

ISSN: 1474-4422

DOI: http://dx.doi.org/10.1016/S1474-4422(10)70043-0



Last updated on 2021-24-06 at 08:27